Neuren Pharmaceuticals Ltd Cash Flow Reinvestment Rate
Neuren Pharmaceuticals Ltd cash flow reinvestment rate. Neuren Pharmaceuticals Ltd (NEU) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting AU$5.00K (capex AU$5.00K ) from operating cash flow of AU$128.31 Million. Explore NEU cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Neuren Pharmaceuticals Ltd (2018–2023)
Cash flow reinvestment rate of Neuren Pharmaceuticals Ltd from 2018 to 2023. Historical reinvestment intensity for Neuren Pharmaceuticals Ltd across 3 annual periods. Explore capital reinvestment ratio of Neuren Pharmaceuticals Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Neuren Pharmaceuticals Ltd Cash Flow Reinvestment Rate by Year (2018–2023)
Neuren Pharmaceuticals Ltd cash flow reinvestment rate by year from 2018 to 2023. Year-by-year capital reinvestment analysis for Neuren Pharmaceuticals Ltd. For the full cash flow conversion analysis, see Neuren Pharmaceuticals Ltd operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.14x | AU$211.53 Million | AU$184.93 Million | AU$40.00K | ▲ +10733.4% |
| 2022 | 0.01x | AU$38.00K | AU$3.60 Million | AU$19.00K | ▲ +463.8% |
| 2018 | 0.00x | AU$12.00K | AU$6.41 Million | AU$12.00K | — |